Skip to main content

To trade in the US, go to polymarket.us

icon for California Immunology Research Bond Proposition
Politics·US Election

California Immunology Research Bond Proposition

icon for California Immunology Research Bond Proposition
Politics·US Election

California Immunology Research Bond Proposition

Nov 3

Nov 3

Nov 3

Nov 3

Nov 3

Nov 3

Nov 3

Nov 3

21% chance
Polymarket
NEW
21% chance
Polymarket
NEW
Proposition 38 is a California ballot measure currently scheduled for voting on November 3, 2026. It would allow the state to borrow $8.4 billion in debt to research immune system-based technologies for treating conditions including cancer, heart disease and Alzheimer’s. This market will resolve to “Yes” if the specified ballot measure is approved by a majority of voters at the California statewide general election currently scheduled for November 3, 2026. Otherwise, this market will resolve to “No.” If voting on the specified ballot measure does not occur, or the results thereof are not known definitively, by March 31, 2027, this market will resolve to “No”. This market will resolve based on a consensus of credible reporting. If there is ambiguity, this market will resolve solely based on official information from the State of California, including the California Secretary of State (https://www.sos.ca.gov/).Voters weigh Proposition 38’s $8.4 billion general obligation bond against its projected $500–600 million annual General Fund repayment cost over roughly 20 years. The measure’s allocation of half the proceeds to one University of California-affiliated institute, selected by the Department of Public Health, has drawn scrutiny over earmarking and limited competitive peer review for that portion. Supporters highlight requirements for independent audits, a 20 percent price discount on resulting therapies for California patients, and potential future royalty offsets, yet the immediate debt service and budget impact appear to shape trader consensus favoring rejection ahead of the November 3, 2026 ballot.

Proposition 38 is a California ballot measure currently scheduled for voting on November 3, 2026. It would allow the state to borrow $8.4 billion in debt to research immune system-based technologies for treating conditions including cancer, heart disease and Alzheimer’s.

This market will resolve to “Yes” if the specified ballot measure is approved by a majority of voters at the California statewide general election currently scheduled for November 3, 2026. Otherwise, this market will resolve to “No.”

If voting on the specified ballot measure does not occur, or the results thereof are not known definitively, by March 31, 2027, this market will resolve to “No”.

This market will resolve based on a consensus of credible reporting. If there is ambiguity, this market will resolve solely based on official information from the State of California, including the California Secretary of State (https://www.sos.ca.gov/).Proposition 38 is a California ballot measure currently scheduled for voting on November 3, 2026. It would allow the state to borrow $8.4 billion in debt to research immune system-based technologies for treating conditions including cancer, heart disease and Alzheimer’s. This market will resolve to “Yes” if the specified ballot measure is approved by a majority of voters at the California statewide general election currently scheduled for November 3, 2026. Otherwise, this market will resolve to “No.” If voting on the specified ballot measure does not occur, or the results thereof are not known definitively, by March 31, 2027, this market will resolve to “No”. This market will resolve based on a consensus of credible reporting. If there is ambiguity, this market will resolve solely based on official information from the State of California, including the California Secretary of State (https://www.sos.ca.gov/).
Volume
$2,892
End Date
Nov 3, 2026
Market Opened
Jul 1, 2026, 6:33 PM ET

Resolver

0x65070BE91...
Proposition 38 is a California ballot measure currently scheduled for voting on November 3, 2026. It would allow the state to borrow $8.4 billion in debt to research immune system-based technologies for treating conditions including cancer, heart disease and Alzheimer’s. This market will resolve to “Yes” if the specified ballot measure is approved by a majority of voters at the California statewide general election currently scheduled for November 3, 2026. Otherwise, this market will resolve to “No.” If voting on the specified ballot measure does not occur, or the results thereof are not known definitively, by March 31, 2027, this market will resolve to “No”. This market will resolve based on a consensus of credible reporting. If there is ambiguity, this market will resolve solely based on official information from the State of California, including the California Secretary of State (https://www.sos.ca.gov/).Voters weigh Proposition 38’s $8.4 billion general obligation bond against its projected $500–600 million annual General Fund repayment cost over roughly 20 years. The measure’s allocation of half the proceeds to one University of California-affiliated institute, selected by the Department of Public Health, has drawn scrutiny over earmarking and limited competitive peer review for that portion. Supporters highlight requirements for independent audits, a 20 percent price discount on resulting therapies for California patients, and potential future royalty offsets, yet the immediate debt service and budget impact appear to shape trader consensus favoring rejection ahead of the November 3, 2026 ballot.

Proposition 38 is a California ballot measure currently scheduled for voting on November 3, 2026. It would allow the state to borrow $8.4 billion in debt to research immune system-based technologies for treating conditions including cancer, heart disease and Alzheimer’s.

This market will resolve to “Yes” if the specified ballot measure is approved by a majority of voters at the California statewide general election currently scheduled for November 3, 2026. Otherwise, this market will resolve to “No.”

If voting on the specified ballot measure does not occur, or the results thereof are not known definitively, by March 31, 2027, this market will resolve to “No”.

This market will resolve based on a consensus of credible reporting. If there is ambiguity, this market will resolve solely based on official information from the State of California, including the California Secretary of State (https://www.sos.ca.gov/).Proposition 38 is a California ballot measure currently scheduled for voting on November 3, 2026. It would allow the state to borrow $8.4 billion in debt to research immune system-based technologies for treating conditions including cancer, heart disease and Alzheimer’s. This market will resolve to “Yes” if the specified ballot measure is approved by a majority of voters at the California statewide general election currently scheduled for November 3, 2026. Otherwise, this market will resolve to “No.” If voting on the specified ballot measure does not occur, or the results thereof are not known definitively, by March 31, 2027, this market will resolve to “No”. This market will resolve based on a consensus of credible reporting. If there is ambiguity, this market will resolve solely based on official information from the State of California, including the California Secretary of State (https://www.sos.ca.gov/).
Volume
$2,892
End Date
Nov 3, 2026
Market Opened
Jul 1, 2026, 6:33 PM ET

Resolver

0x65070BE91...

Related

icon for California Clinic Funding Proposition

California Clinic Funding Proposition

32%
icon for California Homebuying Loan Program Proposition

California Homebuying Loan Program Proposition

52%
icon for California Public Campaign Financing Proposition

California Public Campaign Financing Proposition

43%

Beware of external links.

Frequently Asked Questions

"California Immunology Research Bond Proposition" is a prediction market on Polymarket where traders buy and sell "Yes" or "No" shares based on whether they believe this event will happen. The current crowd-sourced probability is 44% for "Yes." For example, if "Yes" is priced at 44¢, the market collectively assigns a 44% chance that this event will occur. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

"California Immunology Research Bond Proposition" is a newly created market on Polymarket, launched on Jul 1, 2026. As an early market, this is your opportunity to be among the first traders to set the odds and establish the market's initial price signals. You can also bookmark this page to track volume and trading activity as the market gains traction over time.

To trade on "California Immunology Research Bond Proposition," simply choose whether you believe the answer is "Yes" or "No." Each side has a current price that reflects the market's implied probability. Enter your amount and click "Trade." If you buy "Yes" shares and the outcome resolves as "Yes," each share pays out $1. If it resolves as "No," your "Yes" shares pay $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current probability for "California Immunology Research Bond Proposition" is 44% for "Yes." This means the Polymarket crowd currently believes there is a 44% chance that this event will occur. These odds update in real-time based on actual trades, providing a continuously updated signal of what the market expects to happen.

The resolution rules for "California Immunology Research Bond Proposition" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.